09:38 EDT Monte Rosa Therapeutics (GLUE) files $400M mixed securities shelf
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GLUE:
- Monte Rosa Therapeutics Reports Q4 2024 Financial Results
- Monte Rosa Therapeutics announces anticipated upcoming milestones
- Monte Rosa Therapeutics sees cash runway into 2028
- Monte Rosa Therapeutics reports Q4 revenue $60.6M, consensus $51.9M
- Monte Rosa Therapeutics announces results from MRT-6160, MRT-2359 programs